BioDelivery Sciences International Inc logo

BDSI - BioDelivery Sciences International Inc News Story

$3.38 0.2  6.5%

Last Trade - 07/05/21

Sector
Healthcare
Size
Small Cap
Market Cap £244.0m
Enterprise Value £220.3m
Revenue £112.0m
Position in Universe 4014th / 6858

BRIEF-BioDelivery Sciences Says Ohio Workers Compensation Approved Change To Formulary

Mon 27th November, 2017 12:02pm
Nov 27 (Reuters) - BioDelivery Sciences International Inc 
 BDSI.O : 
    * BIODELIVERY SCIENCES - OHIO BUREAU OF WORKERS 
COMPENSATION 
APPROVED CHANGE TO ITS FORMULARY RESULTING IN FAVORABLE 
POSITIONING FOR BELBUCA, BUNAVAIL 
    * BIODELIVERY SCIENCES INTERNATIONAL INC - BELBUCA WILL BE 
ADDED 
TO FORMULARY AS A TIER 1 LONG-ACTING OPIOID WITHOUT 
RESTRICTIONS 
    * BIODELIVERY SCIENCES INTERNATIONAL INC - CHANGES TO 
FORMULARY 
WILL GO INTO EFFECT APRIL 1, 2018 
 
Source text for Eikon:  ID:nPn47tnH5a  
Further company coverage:  BDSI.O  
 
 ((bangalore.newsroom@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.